Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer. 2010 Oct 19;117(6):1113–1122. doi: 10.1002/cncr.25527

Figure 4.

Figure 4

Achievement of major molecular response by 24 months based on molecular responses at 3 and 6 months.29

Reprinted by permission from Macmillan Publishers Ltd: Leukemia. Branford S, Rudzki Z, Harper A, et al. Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. 2003;17(12):2401–2409, © 2003